UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors

Nature reviews cardiology, 2018-12, Vol.15 (12), p.731-743

2018

Volltextzugriff (PDF)

Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality

The New England journal of medicine, 2018-04, Vol.378 (16), p.1509-1520

2018

Volltextzugriff (PDF)

Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure

European heart journal, 2016-09, Vol.37 (33), p.2577-2585

2016

Volltextzugriff (PDF)

Serum Potassium and Clinical Outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)

Circulation (New York, N.Y.), 2008-10, Vol.118 (16), p.1643-1650

2008

Volltextzugriff (PDF)

Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'

Journal of hypertension, 2024-06, Vol.42 (6), p.961

Ruilope, Luis M

2024

Volltextzugriff (PDF)

Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients

Journal of hypertension, 2017-12, Vol.35 (12), p.2388-2394

2017

Volltextzugriff (PDF)

The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease

International journal of molecular sciences, 2024-06, Vol.25 (13), p.7005

2024

Volltextzugriff (PDF)

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials

BMJ open, 2024-03, Vol.14 (3), p.e076444-e076444

2024

Volltextzugriff (PDF)

Prevalence and Clinical Characteristics of Refractory Hypertension

Journal of the American Heart Association, 2017-12, Vol.6 (12), p.n/a

2017

Volltextzugriff (PDF)

Obesity, essential hypertension and renin–angiotensin system

Public health nutrition, 2007-10, Vol.10 (10A), p.1151-1155

2007

Volltextzugriff (PDF)

Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

Journal of the American Society of Nephrology, 2022-01, Vol.33 (1), p.225-237

2022

Volltextzugriff (PDF)

Short‐Term and Long‐Term Reproducibility of Hypertension Phenotypes Obtained by Office and Ambulatory Blood Pressure Measurements

The journal of clinical hypertension (Greenwich, Conn.), 2016-09, Vol.18 (9), p.927-933

2016

Volltextzugriff (PDF)

Diurnal blood pressure variation, risk categories and antihypertensive treatment

Hypertension research, 2010-08, Vol.33 (8), p.767-771

2010

Volltextzugriff (PDF)

Current challenges in the clinical management of hypertension

Nature reviews cardiology, 2012-05, Vol.9 (5), p.267-275

Ruilope, Luis M

2012

Volltextzugriff (PDF)

Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications

The American journal of medicine, 2009-12, Vol.122 (12), p.1136-1141

2009

Volltextzugriff (PDF)

Renal function: the Cinderella of cardiovascular risk profile

Journal of the American College of Cardiology, 2001-12, Vol.38 (7), p.1782-1787

2001

Volltextzugriff (PDF)

High prevalence of masked uncontrolled hypertension in people with treated hypertension

European heart journal, 2014-12, Vol.35 (46), p.3304-3312

2014

Volltextzugriff (PDF)

Ambulatory Blood Pressure in Hypertensive Patients with Inclusion Criteria for the SPRINT Trial

Journal of the American Society of Hypertension, 2016-12, Vol.10 (12), p.947-953.e5

2016

Volltextzugriff (PDF)

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression

Cardiovascular diabetology, 2016-01, Vol.15 (1), p.8, Article 8

2016

Volltextzugriff (PDF)

Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study

European journal of preventive cardiology, 2022-03, Vol.29 (2), p.e50-e52

2022

Volltextzugriff (PDF)

Renal function and target organ damage in hypertension

European heart journal, 2011-07, Vol.32 (13), p.1599-1604

2011

Volltextzugriff (PDF)

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension

Kidney international, 2004-11, Vol.66 (S92), p.S45-S49

2004

Volltextzugriff (PDF)

Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients

Journal of hypertension, 2017-12, Vol.35 (12), p.2517-2526

2017

Volltextzugriff (PDF)

The kidney as a sensor of cardiovascular risk in essential hypertension

Journal of the American Society of Nephrology, 2002-11, Vol.13 (11), p.165-168

RUILOPE, Luis M

2002

Volltextzugriff (PDF)

Predictors for the development of microalbuminuria and interaction with renal function

Journal of hypertension, 2017-12, Vol.35 (12), p.2501-2509

2017

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Aktive Filter

ThemaBlood Pressure - Drug Effects

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(123)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(105)
Science & Technology
(94)
Life Sciences & Biomedicine
(93)
Cardiovascular System & Cardiology
(63)
Male
(43)
Female
(41)
Peripheral Vascular Disease
(41)
Aged
(38)
Hypertension
(37)
Middle Aged
(37)
Hypertension - Complications
(34)
Hypertension - Drug Therapy
(30)
Biological And Medical Sciences
(27)
Hypertension - Physiopathology
(27)
Medical Sciences
(27)
Antihypertensive Agents - Therapeutic Use
(26)
Blood Pressure
(24)
Cardiac & Cardiovascular Systems
(24)
Cardiovascular Disease
(20)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors

Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality

Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure

Serum Potassium and Clinical Outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)

Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'

Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients

The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials

Prevalence and Clinical Characteristics of Refractory Hypertension

Obesity, essential hypertension and renin–angiotensin system

Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

Short‐Term and Long‐Term Reproducibility of Hypertension Phenotypes Obtained by Office and Ambulatory Blood Pressure Measurements

Diurnal blood pressure variation, risk categories and antihypertensive treatment

Current challenges in the clinical management of hypertension

Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications

Renal function: the Cinderella of cardiovascular risk profile

High prevalence of masked uncontrolled hypertension in people with treated hypertension

Ambulatory Blood Pressure in Hypertensive Patients with Inclusion Criteria for the SPRINT Trial

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression

Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study

Renal function and target organ damage in hypertension

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension

Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients

The kidney as a sensor of cardiovascular risk in essential hypertension

Predictors for the development of microalbuminuria and interaction with renal function

Aktive Filter

Suchergebnisse filtern